...
首页> 外文期刊>Journal of cellular and molecular medicine. >High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
【24h】

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

机译:高醛脱氢酶和癌干细胞标志物的表达选择具有增强的恶性和转移能力的乳腺癌细胞

获取原文
           

摘要

Cancer stem cells (CSCs) have recently been identified in leukaemia and solid tumours; however, the role of CSCs in metastasis remains poorly understood. This dearth of knowledge about CSCs and metastasis is due largely to technical challenges associated with the use of primary human cancer cells in pre-clinical models of metastasis. Therefore, the objective of this study was to develop suitable pre-clinical model systems for studying stem-like cells in breast cancer metastasis, and to test the hypothesis that stem-like cells play a key role in metastatic behaviour. We assessed four different human breast cancer cell lines (MDA-MB-435, MDA-MB-231, MDA-MB-468, MCF-7) for expression of prospective CSC markers CD44/CD24 and CD133, and for functional activity of aldehyde dehydrogenase (ALDH), an enzyme involved in stem cell self-protection. We then used fluorescence-activated cell sorting and functional assays to characterize differences in malignant/metastatic behaviour in vitro (proliferation, colony-forming ability, adhesion, migration, invasion) and in vivo (tumorigenicity and metastasis). Sub-populations of cells demonstrating stem-cell-like characteristics (high expression of CSC markers and/or high ALDH) were identified in all cell lines except MCF-7. When isolated and compared to ALDHlowCD44low/– cells, ALDHhiCD44+CD24? (MDA-MB-231) and ALDHhiCD44+CD133+ (MDA-MB-468) cells demonstrated increased growth (P receptor null mice, ALDHhiCD44+CD24? and ALDHhiCD44+CD133+ cells showed enhanced tumorigenicity and metastasis relative to ALDHlowCD44low/– cells (P hiCD44+CD24? and ALDHhiCD44+CD133+ cells may be important mediators of breast cancer metastasis.
机译:最近在白血病和实体瘤中发现了癌症干细胞(CSC)。然而,CSCs在转移中的作用仍然知之甚少。关于CSCs和转移的知识匮乏主要是由于与临床前转移模型中原发性人类癌细胞的使用相关的技术挑战。因此,本研究的目的是开发合适的临床前模型系统,以研究乳腺癌转移中的干细胞样细胞,并检验干细胞样细胞在转移行为中起关键作用的假设。我们评估了四种不同的人类乳腺癌细胞系(MDA-MB-435,MDA-MB-231,MDA-MB-468,MCF-7)表达预期的CSC标记CD44 / CD24和CD133,以及醛的功能活性脱氢酶(ALDH),一种参与干细胞自我保护的酶。然后,我们使用荧光激活的细胞分选和功能测定来表征体外(增殖,集落形成能力,粘附,迁移,侵袭)和体内(致瘤性和转移)恶性/转移行为的差异。在除MCF-7以外的所有细胞系中都鉴定出了具有干细胞样特征(CSC标记物的高表达和/或高ALDH)的细胞亚群。当分离并与ALDH low CD44 low / – 细胞进行比较时,ALDH hi CD44 + CD24 (MDA-MB-231)和ALDH hi CD44 + CD133 + (MDA-MB-468)细胞表现出增加的生长(P受体无效小鼠,ALDH hi CD44 + CD24 和ALDH hi CD44 + low CD44 low / – 细胞(P hi CD44 ),SUP> CD133 + 细胞显示出更高的致瘤性和转移能力。 > + CD24 和ALDH hi CD44 + CD133 + 细胞可能是乳腺癌的重要介质癌转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号